Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study

Journal article

Elneima O. et al, (2024), International Journal of Epidemiology, 53

Balancing the value and risk of exercise-based therapy post-COVID-19: a narrative review.

Journal article

Singh SJ. et al, (2023), Eur Respir Rev, 32

Synbiotics in post-acute COVID-19 syndrome-a potential new treatment framework?

Journal article

Raman B. and Ramasamy MN., (2023), Lancet Infect Dis

Long COVID research: an update from the PHOSP-COVID Scientific Summit.

Journal article

Brightling CE. et al, (2023), Lancet Respir Med, 11, e93 - e94

Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study.

Journal article

C-MORE/PHOSP-COVID Collaborative Group None., (2023), Lancet Respir Med, 11, 1003 - 1019

Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathy.

Journal article

Farrant J. et al, (2023), Heart, 109, 1175 - 1182

Mechanisms and prognostic impact of myocardial ischaemia in hypertrophic cardiomyopathy.

Journal article

Coleman JA. et al, (2023), Int J Cardiovasc Imaging

Left ventricular anatomy in obstructive hypertrophic cardiomyopathy: beyond basal septal hypertrophy.

Journal article

Hermida U. et al, (2023), Eur Heart J Cardiovasc Imaging, 24, 807 - 818

Load More